ACTRN12611001013954已完成未知
A placebo controlled, cross-over trial investigating the effect of dairy-derived proteins on circulating lipids and related cardiovascular risk factors in mildly hypercholesterolaemic individuals
actoPharma0 个研究点目标入组 25 人开始时间: 2011年9月21日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- Male
入选标准
- •1. mild hypercholesterolaemia; fasted LDL-C > 3.0 mmol/L
- •2. no clinical intervention or drug treatment for hyperlipidaemia
- •3. no previous cardiovascular events
- •4. no evidence of end organ damage
- •5. willingness to participate in a clinical trial
排除标准
- •1. allergy to milk or dairy products
- •2. treatment for lipid disorders
- •3. treatment for hypertension
- •4. significant metabolic disorders, including diabetes mellitus, significant renal impairment (serum creatinine>130mmol/L; EGFR<60) or other disease
- •6. participation in another clinical intervention trial
研究者
相似试验
已完成
不适用
A placebo-controlled, crossover trial to investigate the efficacy of Tiotropium Bromide or Placebo added to usual care in stable symptomatic post-Hematopoietic Stem Cell Transplantation (HSCT) Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis obliterans.Other specified interstitial pulmonary diseasesJ84.89IRCT20200415047080N3The pulmonary disease research center24
已完成
不适用
Treatment of type 2 diabetes with antioxidant vitamin C therapyType 2 diabetesskeletal muscle insulin resistanceAlternative and Complementary Medicine - Other alternative and complementary medicineMetabolic and Endocrine - DiabetesACTRN12614000239662Deakin University24
进行中（未招募）
1 期
A randomised, placebo-controlled, crossover study to measure the effect of alosetron on mucosal blood flow in female healthy volunteers and diarrhea-predominant IBS subjects - N/AIrritable Bowel Syndrome (IBS)EUCTR2005-003319-64-GBGlaxoSmithKline Research and Development Limited
进行中（未招募）
1 期
improvement of cognitive performance after administration of fampridina in patients with multiple sclerosisMedDRA version: 20.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMULTIPLE SCLEROSISEUCTR2013-002558-64-ITdipartimento di neurologia e psichiatria123
尚未招募
不适用
A micronutrient intervention for students experiencing stressAnxietyACTRN12620000551998niversity of Canterbury, School of Psychology, Speech, and Hearing120